Roche vs Cipla: Pondering the Puzzle
The much awaited Roche vs Cipla judgment is out. And much like the Ayodhya judgment, it runs into innumerable pages, ensuring that only the most perseverant brave through it. Rated as India’s first drug patent decision in the post TRIPS era (post trial), it marks an important watershed in Indian patent history. I have managed just one quick reading of the decision and will therefore offer very tentative observations and raise some questions. As Shouvik noted in his post here, […]
Roche vs Cipla: Pondering the Puzzle Read More »





